MiRNA-610 acts as a tumour suppressor to depress the cisplatin resistance in hepatocellular carcinoma through targeted silencing of hepatoma-derived growth factor

INTRODUCTION: Hepatic malignancy is one of the most common malignant neoplasms around the globe, and hepatocellular carcinoma (HCC) is the most common type. In this study, the roles and mechanisms of MiRNA-610 in the chemo resistance of HCC will be discussed. MATERIAL AND METHODS: The expression of...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yongqing, Wang, Helin, Gao, Weike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2019
Materias:
Basic Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667417/
https://www.ncbi.nlm.nih.gov/pubmed/33224339
http://dx.doi.org/10.5114/aoms.2019.87938

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667417/
https://www.ncbi.nlm.nih.gov/pubmed/33224339
http://dx.doi.org/10.5114/aoms.2019.87938

Ejemplares similares